Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

Pursuing the world's first-ever orally-dosed liraglutide KELOWNA, BC / ACCESS Newswire / February 20, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global ...

West Pharmaceutical’s earnings results led to a 38% drop. Find out why WST stock could be worth watching for future rebounds ...

For reference, 1 kg is about 2.2 pounds ... Your doctor will prescribe the drug and dosage that’s right for you. To learn more about how these drugs compare, talk with your doctor.

Displaying articles to out of total. Displaying articles to out of total.

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

CardCash.com to Offer Cost-Effective Solutions for High-Demand GLP-1 Medications as Prescription Drug Market Grows SCHAUMBURG, IL / ACCESS ...

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...

For some, that extended to alcohol, too. Now, the growing buzz around the use of GLP-1 medications like Ozempic to treat alcohol use disorder finally has new clinical study results that support ...

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...